VISION & MISSION

vision

OUR VISION

We intend to become a leading global player in neurodegenerative diseases, starting with Alzheimer’s, by developing an innovative portfolio of therapeutics based on proprietary technology platforms as well as in-licensing technologies, driven by biomarkers, and established by safety and efficacy in patients.

mission

OUR MISSION

Our mission is to address the social and economic burden of neurodegenerative diseases such as Alzheimer’s. We are a clinical stage biotech company that seeks to rapidly advance candidates into and through clinical trials with the goal of delivering breakthrough treatments to patients within the next 5-7 years.